泰国孕妇对新冠疫苗的接受情况
COVID-19 Vaccine Acceptance of Pregnant Women in Thailand.
作者信息
Nirunrungraung Bornpavi, Lattiwongsakorn Worashorn, Piyamongkol Wirawit
机构信息
Department of Obstetrics and Gynaecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
出版信息
Int J Womens Health. 2024 May 18;16:865-876. doi: 10.2147/IJWH.S457740. eCollection 2024.
OBJECTIVE
This study investigated the COVID-19 vaccine acceptance rate among pregnant women in Thailand and explored factors influencing their willingness to receive the vaccine, to enhance vaccine uptake among hesitant pregnant women in the future.
METHODS
A prospective study was conducted at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, in October 2022. The data was collected using face-to-face questionnaires comprising 29 closed-end questions. Pregnant women aged 18 years old or over visiting the antenatal care clinic were included.
RESULTS
The study included 200 participants, revealing a COVID-19 vaccine acceptance rate of 17%. Healthcare provider recommendations significantly increased vaccine acceptance by nearly two-fold (30.77%, p-value < 0.01). The major cause of vaccine hesitancy was the concern about vaccine safety that potentially harmed their babies (77.44%).
CONCLUSION
The COVID-19 vaccine acceptance rate among pregnant women in Thailand was low. Healthcare provider recommendations played a pivotal role in positively impacting vaccine acceptance, highlighting their importance in increasing acceptance rates in the future.
目的
本研究调查了泰国孕妇对新冠疫苗的接受率，并探讨了影响她们接种疫苗意愿的因素，以便未来提高犹豫不决的孕妇的疫苗接种率。
方法
2022年10月在泰国清迈的玛哈叻那空清迈医院进行了一项前瞻性研究。数据通过包含29个封闭式问题的面对面问卷调查收集。纳入年龄在18岁及以上前往产前护理诊所的孕妇。
结果
该研究包括200名参与者，新冠疫苗接受率为17%。医疗保健提供者的建议使疫苗接受率显著提高了近两倍（30.77%，p值<0.01）。疫苗犹豫的主要原因是担心疫苗安全可能会伤害她们的婴儿（77.44%）。
结论
泰国孕妇对新冠疫苗的接受率较低。医疗保健提供者的建议对积极影响疫苗接受率起到了关键作用，凸显了其在未来提高接受率方面的重要性。
Zotero 插件